Well shit what is it? There are these other pieces of research out there. We don't care about prevalence, just give us protocols to prevent it. Or don't you understand what stroke survivors want?
1. A documented 33% dementia chance post-stroke from an Australian study? May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
3. A 20% chance in this research. July 2013.
4. Dementia Risk Doubled in Patients Following Stroke September 2018
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study
Summary
Background
Risk
of dementia after stroke is a major concern for patients and carers.
Reliable data for risk of dementia, particularly after transient
ischaemic attack or minor stroke, are scarce. We studied the risks of,
and risk factors for, dementia before and after transient ischaemic
attack and stroke.
Methods
The
Oxford Vascular Study is a prospective incidence study of all vascular
events in a population of 92 728 people residing in Oxfordshire, UK.
Patients with transient ischaemic attack or stroke occurring between
April 1, 2002, and March 31, 2012, were ascertained with multiple
methods, including assessment in a dedicated daily emergency clinic and
daily review of all hospital admissions. Pre-event and post-event
(incident) dementia were diagnosed at initial assessment and during
5-years' follow-up on the basis of cognitive testing supplemented by
data obtained from hand searches of all hospital and primary care
records. We assessed the association between post-event dementia and
stroke severity (as measured with the US National Institutes of Health
Stroke Scale [NIHSS] score), location (ie, dysphasia), previous events,
markers of susceptibility or reserve (age, low education, pre-morbid
dependency, leucoaraiosis), baseline cognition, and vascular risk
factors with Cox regression models adjusted for age, sex, and education.
We compared incidence and prevalence of dementia in our population with
published UK population age-matched and sex-matched rates.
Findings
Among
2305 patients (mean age 74·4 years [SD 13·0]), 688 (30%) had transient
ischaemic attacks and 1617 (70%) had strokes. Pre-event dementia was
diagnosed in 225 patients; prevalence was highest in severe stroke (ie,
NIHSS >10) and lowest in transient ischaemic attack. Of 2080 patients
without pre-event dementia, 1982 (95%) were followed up to the end of
study or death. Post-event dementia occurred in 432 of 2080 patients
during 5 years of follow-up. The incidence of post-event dementia at 1
year was 34·4% (95% CI 29·7–41·5) in patients with severe stroke (NIHSS
score >10), 8·2% (6·2–10·2) in those with minor stroke (NIHSS score
<3), and 5·2% (3·4–7·0) in those with transient ischaemic attack.
Compared with the UK age-matched and sex-matched population, the 1-year
standardised morbidity ratio for the incidence of dementia was 47·3 (95%
CI 35·9–61·2), 5·8 (4·4–7·5), and 3·5 (2·5–4·8), respectively.
Consequently, prevalence of dementia in 1-year survivors was brought
forward by approximately 25 years in those who had severe strokes, 4
years in those who had minor strokes, and 2 years in those who had
transient ischaemic attacks. 5-year risk of dementia was associated with
age, event severity, previous stroke, dysphasia, baseline cognition,
low education, pre-morbid dependency, leucoaraiosis, and diabetes
(p<0·0001 for all comparisons, except for previous stroke [p=0·006]).
Interpretation
The
incidence of dementia in patients who have had a transient ischaemic
attack or stroke varies substantially depending on clinical
characteristics including lesion burden and susceptibility factors.
Incidence of dementia is nearly 50 times higher in the year after a
major stroke compared with that in the general population, but excess
risk is substantially lower after transient ischaemic attack and minor
stroke.
Funding
Wellcome
Trust, Wolfson Foundation, British Heart Foundation, National Institute
for Health Research, and the National Institute for Health Research
Oxford Biomedical Research Centre.
No comments:
Post a Comment